RBC Capital Remains a Buy on Astera Labs, Inc. (ALAB)

RBC Capital analyst Srini Pajjuri reiterated a Buy rating on Astera Labs, Inc. today and set a price target of $225.00.

Valentine's Day Sale - 70% Off

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Pajjuri covers the Technology sector, focusing on stocks such as Advanced Micro Devices, Intel, and ASML Holding. According to TipRanks, Pajjuri has an average return of 36.0% and a 75.00% success rate on recommended stocks.

In addition to RBC Capital, Astera Labs, Inc. also received a Buy from Needham’s Quinn Bolton in a report issued today. However, yesterday, Bank of America Securities reiterated a Hold rating on Astera Labs, Inc. (NASDAQ: ALAB).

Based on Astera Labs, Inc.’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $230.58 million and a net profit of $91.11 million. In comparison, last year the company earned a revenue of $113.09 million and had a GAAP net loss of $7.59 million

Based on the recent corporate insider activity of 85 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ALAB in relation to earlier this year. Most recently, in November 2025, Sanjay Gajendra, the President & COO of ALAB sold 90,459.00 shares for a total of $13,088,450.00.